Ironwood Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$744K Buy
53,212
+3,907
+8% +$54.7K 0.36% 85
2025
Q1
$670K Buy
49,305
+12,759
+35% +$173K 0.37% 83
2024
Q4
$745K Sell
36,546
-38
-0.1% -$774 0.37% 83
2024
Q3
$1.07M Buy
36,584
+355
+1% +$10.3K 0.52% 65
2024
Q2
$841K Buy
36,229
+165
+0.5% +$3.83K 0.45% 73
2024
Q1
$740K Buy
36,064
+18,126
+101% +$372K 0.36% 83
2023
Q4
$385K Sell
17,938
-158
-0.9% -$3.39K 0.2% 112
2023
Q3
$373K Sell
18,096
-623
-3% -$12.9K 0.23% 104
2023
Q2
$552K Sell
18,719
-77
-0.4% -$2.27K 0.32% 88
2023
Q1
$433K Sell
18,796
-353
-2% -$8.13K 0.27% 105
2022
Q4
$533K Sell
19,149
-759
-4% -$21.1K 0.35% 90
2022
Q3
$611K Buy
19,908
+52
+0.3% +$1.6K 0.43% 86
2022
Q2
$584K Buy
19,856
+14
+0.1% +$412 0.39% 90
2022
Q1
$638K Buy
19,842
+459
+2% +$14.8K 0.35% 99
2021
Q4
$864K Buy
19,383
+290
+2% +$12.9K 0.43% 79
2021
Q3
$963K Buy
19,093
+19
+0.1% +$958 0.5% 68
2021
Q2
$1.5M Sell
19,074
-446
-2% -$35K 0.76% 38
2021
Q1
$1.12M Buy
19,520
+155
+0.8% +$8.85K 0.59% 62
2020
Q4
$1.62M Sell
19,365
-553
-3% -$46.3K 0.95% 28
2020
Q3
$714K Sell
19,918
-40
-0.2% -$1.43K 0.51% 78
2020
Q2
$483K Sell
19,958
-112
-0.6% -$2.71K 0.38% 100
2020
Q1
$351K Sell
20,070
-741
-4% -$13K 0.35% 104
2019
Q4
$363K Sell
20,811
-1,696
-8% -$29.6K 0.25% 121
2019
Q3
$345K Sell
22,507
-88
-0.4% -$1.35K 0.26% 119
2019
Q2
$469K Sell
22,595
-12
-0.1% -$249 0.37% 101
2019
Q1
$525K Buy
22,607
+12,515
+124% +$291K 0.43% 89
2018
Q4
$209K Buy
+10,092
New +$209K 0.19% 137